A platform led by Professor Jörg Fritz of McGill University to stimulate the discovery and development of new RNA vaccines.
Vaccines are essential for preventing infections and represent a cornerstone of strategies aimed at preparing for future epidemics and pandemics. The development of new RNA vaccines against emerging pathogens relies on the rapid identification of antigenic targets capable of eliciting effective protection against infection. However, this crucial step is often limited by the lack of efficient screening tools. Moreover, there is a need for a preclinical platform to evaluate new formulations and the effectiveness of RNA vaccines.
